Symbol
| CA9
| contributors: mct - updated : 27-08-2013
|
HGNC name
| carbonic anhydrase IX
|
HGNC id
| 1383
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in some human carcinomas | tumoral
|  
|  
| --over
|  
|
in MnSOD-positive oligodendroglial brain tumors | tumoral
|  
|  
| --over
|  
|
in hereditary nonpolyposis colorectal cancer | tumoral
|  
|  
| --over
|  
|
induces weakening of cell adhesions and augmented cell motility by aberrant Rho-GTPase signal transduction ( | tumoral
|  
|  
| --over
|  
|
in glioblastoma | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| is an independent prognostic factor for poor outcome in patients with glioblastoma | |
biomarker of aggressive disease in neuroblastomas | Therapy target
|
System | Type | Disorder | Pubmed |
tumor | | | |
inhibition of CA9 activity may offer a novel strategy for the clinical treatment of CA9-associated tumors | cancer | brain | glioma/neuroblstoma | |
inhibition of CA9is a potential metabolic target for the treatment of patients with glioblastoma |
| | |